Healthcare Services

Rising Prevalence Of Respiratory Diseases Is Driving The Growth Of The Market Continues To Impact The Growth Of The Acute Lung Injury Market

May 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Rise In Market Size Of The Acute Lung Injury Market During The Forecast Period?

The acute lung injury market size has experienced consistent expansion recently. Projections indicate its value will rise from $2.59 billion in 2025 to $2.71 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 4.4%. Historical growth can be ascribed to several factors, including the widespread occurrence of pneumonia and lung injuries caused by trauma, restricted availability of sophisticated ventilation equipment, increasing recognition of critical care needs, the implementation of standard fluid management guidelines, and a dependence on treatments administered in hospitals.

The acute lung injury market is projected to experience consistent expansion in the coming years. This market is anticipated to reach $3.19 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.2%. Factors driving this growth during the projection period include the introduction of innovative pharmacotherapies for ALI, greater incorporation of AI in patient surveillance, the global increase in intensive care units, wider acceptance of tailored treatment strategies, and improvements in less invasive ventilation techniques. Key trends anticipated within this forecast timeframe encompass a global surge in acute lung injury incidents, enhanced utilization of mechanical ventilation, an expanding application of pharmacotherapy and fluid management, a stronger emphasis on early detection and monitoring instruments, and the expansion of critical care services within hospitals.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20704&type=smp

Which Strategic Drivers Are Supporting The Acute Lung Injury Market Development?

The increasing occurrence of respiratory ailments is projected to fuel the expansion of the acute lung injury market in the coming years. These conditions encompass a range of disorders impacting the lungs and other components of the respiratory system, resulting in breathing difficulties and diminished lung functionality. The growing incidence of respiratory illnesses can be attributed to factors such as elevated air pollution, tobacco use, inactive lifestyles, an aging demographic, and the effects of viral infections. Conditions like pneumonia, which fall under respiratory diseases, lead to acute lung injury by initiating significant inflammation and harming the alveoli, thus impeding gas exchange and causing respiratory distress. For example, reports from the National Asthma Council, an Australia-based non-profit organization, in October 2024 indicated that Australia saw a total of 474 asthma-related fatalities in 2023, with 325 being females and 149 males. This number closely mirrors the 473 asthma-related deaths documented in 2022, underscoring a consistent pattern in asthma mortality across these two years. Consequently, the increasing occurrence of respiratory diseases is propelling the expansion of the acute lung injury market.

How Does Segment Analysis Break Down The Acute Lung Injury Market Structure?

The acute lung injury market covered in this report is segmented –

1) By Injury Type: Direct Injury, Indirect Injury

2) By Therapy: Mechanical Ventilation, Pharmacotherapy, Fluid Management, Other Therapies

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Direct Injury: Trauma-Induced Acute Lung Injury, Aspiration Pneumonitis, Pneumonia-Related Acute Lung Injury, Inhalation Injury

2) By Indirect Injury: Sepsis-Related Acute Lung Injury, Shock-Induced Acute Lung Injury, Acute Lung Injury Due To Blood Transfusion, Acute Lung Injury Associated With Pancreatitis

What Trends Are Influencing The Acute Lung Injury Market Outlook?

Leading firms within the acute lung injury treatment market are concentrating on creating sophisticated therapies, including recombinant human plasma gelsolin (rhu-pGSN), with the aim of restoring balance to dysfunctional inflammation, governing vital immune responses, and potentially enhancing patient results in cases of severe lung injury. This therapy, rhu-pGSN, is derived from gelsolin, a well-preserved protein instrumental in managing immune imbalance associated with acute respiratory distress syndrome (ARDS). As an example, BioAegis Therapeutics, a US-based biotech enterprise, was granted Fast Track designation by the U.S. Food and Drug Administration (FDA) in June 2025 for rhu-pGSN, its primary candidate product, specifically for treating ARDS. The therapy provides distinct advantages, such as re-establishing equilibrium in dysfunctional inflammation without suppressing immunity, modulating essential immune reactions within the lungs, and offering the potential to better outcomes for individuals suffering from severe inflammatory lung injury.

Which Companies Are Engaged In The Acute Lung Injury Market Environment?

Major companies operating in the acute lung injury market are Medtronic plc, Baxter International Inc., GE Healthcare Technologies Inc., Drägerwerk AG & Co. KGaA, Getinge AB, Koninklijke Philips N.V., Hamilton Medical AG, Vyaire Medical Inc., Vapotherm Inc., GlaxoSmithKline plc, AstraZeneca plc, Boehringer Ingelheim International GmbH, Faron Pharmaceuticals Oy, Windtree Therapeutics Inc., Apeiron Biologics AG, ReAlta Life Sciences Inc., Vasomune Therapeutics Inc., MediciNova Inc., Ono Pharmaceutical Co. Ltd., Pfizer Inc.

Access The Complete Acute Lung Injury Market Report:

https://www.thebusinessresearchcompany.com/report/acute-lung-injury-global-market-report

Which Region Is The Primary Market For The Acute Lung Injury Market?

North America was the largest region in the acute lung injury market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute lung injury market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Acute Lung Injury Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20704&type=smp

Browse Through More Reports Similar to the Global Acute Lung Injury Market 2026, By The Business Research Company

Interstitial Lung Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/interstitial-lung-disease-global-market-report

Acute Respiratory Distress Syndrome Ards Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-respiratory-distress-syndrome-ards-global-market-report

Acute Spinal Cord Injury Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795